US 10485883 — Patent Expiration

ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US10485883

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 10485883

Adeno-associated Virus (aav) Clades, Sequences, Vectors Containing Same, And Uses Therefor

High Confidence

Application No. 15433322

September 30, 2024

Expired 648 days ago

Earliest effective filing

Sep 30, 2004

+ 20 years

Sep 30, 2024

PTA +0d

Sep 30, 2024

TD applied

Sep 30, 2024

Final

Sep 30, 2024

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Note: terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation Details

Base Term Calculation

Filing Date

February 15, 2017

Earliest Effective Filing

September 30, 2004

Issue Date

November 26, 2019

PTA

0 days

Base Expiry (before PTA)

September 30, 2024

September 30, 2004 + 20 years = September 30, 2024

Continuation of application 15227418, filed Aug 3, 2016, issued as US 10265417

Continuation of application 13023918, filed Feb 9, 2011

Continuation of application 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of application PCTUS2004028817, filed Sep 30, 2004

Continuation of application 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of application PCTUS2004028817, filed Sep 30, 2004

Continuation of application 13023918, filed Feb 9, 2011

Continuation of application 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of application PCTUS2004028817, filed Sep 30, 2004

PRO

60508226 — Provisional — not used for base term

PRO

60566546 — Provisional — not used for base term

PRO

60508226 — Provisional — not used for base term

PRO

60566546 — Provisional — not used for base term

PRO

60508226 — Provisional — not used for base term

PRO

60566546 — Provisional — not used for base term

PRO

60566546 — Provisional — not used for base term

PRO

60508226 — Provisional — not used for base term

PRO

60508226 — Provisional — not used for base term

PRO

60566546 — Provisional — not used for base term

Terminal Disclaimer Analysis

TD Approved

3 approved, 3 filed

TD caps expiration to September 30, 2024

US 10485883(App. 15433322)(from app 15433322)

Capping Patent

Adeno-associated Virus (aav) Clades, Sequences, Vectors Containing Same, And Uses Therefor

Filing Date

Feb 15, 2017

Earliest Effective Filing

Sep 30, 2004

Issue Date

Nov 26, 2019

PTA

0 days

Calculated Expiration

Sep 30, 2024

Continuation of 15227418, filed Aug 3, 2016, issued as US 10265417

Continuation of 13023918, filed Feb 9, 2011

Continuation of 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Continuation of 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Continuation of 13023918, filed Feb 9, 2011

Continuation of 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Sep 30, 2004 + 20y = Sep 30, 2024

US 10406173(App. 15862999)(from app 15862999)

Compositions And Methods For Altering Tissue Specificity And Improving Aav9-mediated Gene Transfer

Filing Date

Jan 5, 2018

Earliest Effective Filing

Feb 17, 2012

Issue Date

Sep 10, 2019

PTA

0 days

Calculated Expiration

Feb 17, 2032

Divisional of 13985630, filed Aug 15, 2013, issued as US 9884071

National Stage Entry of PCTUS2012025550, filed Feb 17, 2012

Feb 17, 2012 + 20y = Feb 17, 2032

US 7906111(App. 10573600)

Adeno-associated Virus (aav) Clades, Sequences, Vectors Containing Same, And Uses Therefor

Filing Date

Mar 24, 2006

Earliest Effective Filing

Sep 30, 2004

Issue Date

Mar 15, 2011

PTA

+473 days

Calculated Expiration

Jan 16, 2026

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Sep 30, 2004 + 20y + 473d PTA = Jan 16, 2026

US 10265417(App. 15227418)(from app 15227418)

Adeno-associated Virus (aav) Clades, Sequences, Vectors Containing Same, And Uses Therefor

Filing Date

Aug 3, 2016

Earliest Effective Filing

Sep 30, 2004

Issue Date

Apr 23, 2019

PTA

0 days

Calculated Expiration

Sep 30, 2024

Continuation of 13023918, filed Feb 9, 2011

Continuation of 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Continuation of 10573600, filed Mar 24, 2006, issued as US 7906111

National Stage Entry of PCTUS2004028817, filed Sep 30, 2004

Sep 30, 2004 + 20y = Sep 30, 2024

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.